PMC:7443692 / 3027-3350 JSONTXT

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T2","span":{"begin":275,"end":304},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T15","span":{"begin":275,"end":286},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T21","span":{"begin":228,"end":238},"obj":"Species"},{"id":"T22","span":{"begin":245,"end":253},"obj":"Species"}],"attributes":[{"id":"A21","pred":"ncbi_taxonomy_id","subj":"T21","obj":"NCBItxid:2697049"},{"id":"A22","pred":"ncbi_taxonomy_id","subj":"T22","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T14","span":{"begin":228,"end":238},"obj":"Disease"},{"id":"T15","span":{"begin":245,"end":253},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T281","span":{"begin":275,"end":306},"obj":"Protein"},{"id":"T296","span":{"begin":308,"end":312},"obj":"Protein"}],"attributes":[{"id":"A281","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A282","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q9NRA7"},{"id":"A283","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q9BYF1"},{"id":"A284","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q99N71"},{"id":"A285","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q99N70"},{"id":"A286","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q8R0I0"},{"id":"A287","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q86WT0"},{"id":"A288","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q6UWP0"},{"id":"A289","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q5RFN1"},{"id":"A290","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q5EGZ1"},{"id":"A291","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q58DD0"},{"id":"A292","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q56NL1"},{"id":"A293","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q56H28"},{"id":"A294","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/Q2PGE2"},{"id":"A295","pred":"uniprot_id","subj":"T281","obj":"https://www.uniprot.org/uniprot/C7ECU1"},{"id":"A296","pred":"uniprot_id","subj":"T296","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T14","span":{"begin":43,"end":50},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T15","span":{"begin":270,"end":274},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}

{"project":"2_test","denotations":[{"id":"32841605-32376394-19659461","span":{"begin":87,"end":91},"obj":"32376394"},{"id":"32841605-32311843-19659462","span":{"begin":127,"end":131},"obj":"32311843"},{"id":"32841605-32267560-19659463","span":{"begin":163,"end":167},"obj":"32267560"},{"id":"32841605-32566561-19659464","span":{"begin":202,"end":206},"obj":"32566561"},{"id":"32841605-32220112-19659465","span":{"begin":221,"end":225},"obj":"32220112"}],"text":" likely reduce the duration of symptomatic disease presentation (Alijotas-Reig et al., 2020; Beigel et al., 2020; Beun et al., 2020; Dashti-Khavidaki and Khalili, 2020; Fedson et al., 2020; Shi et al., 2020; Tang et al., 2020).\nSARS-CoV-2, like SARS-CoV-1, utilizes the host angiotensin-converting enzyme 2 (ACE2) for bindi"}